Regeneron Pharmaceuticals | REGN - Devedores Comerciais





Devedores Comerciais Alterar Data
AbbVie USD 12.59B 180M 2025-12
Agenus USD 22.44M 1.14M 2025-12
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Amgen USD 9.14B 432M 2026-03
Astellas Pharma JPY 761.76B 48.47B 2026-03
AstraZeneca USD 17.88B 1.17B 2026-03
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Eli Lilly USD 21.18B 1.02B 2026-03
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Gilead Sciences USD 4.74B 172M 2026-03
GlaxoSmithKline GBP 7.94B 178M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Ionis Pharmaceuticals USD 74M 8M 2026-03
J&J USD 21.33B 3.72B 2025-12
Kyowa Hakko Kirin JPY 120.9B 60.31B 2026-03
Merck USD 11.78B 345M 2025-12
Moderna USD 71M 113M 2026-03
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
Novartis USD 9.6B 2.69B 2026-03
Novartis USD 12.29B 3.3B 2025-12
Pfizer USD 16.17B 332M 2026-03
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 397M 186.13M 2025-12
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Teva Pharmaceutical Industries USD 3.39B 316M 2026-03
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
United Therapeutics USD 312M 38.2M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03